Lynne H. Brum
VP, Corp. Comm.&Financial Plan, Vertex Pharmaceuticals.
Companies
- Yield10 BioscienceVP Marketing and Corp Comm Nov 21, 2011 to Aug 19, 20241
- Vertex PharmaceuticalsVP, Corp. Comm.&Financial Plan Jan 18, 2006 to May 9, 20062
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Yield10 Bioscience YTEN7,923 shares3Aug 19, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 15, 2024Shares withheld for tax 731 shares at $1.50 of Yield10 Bioscience3
- Feb 15, 2024Granted 100,000 shares at $0.30 of Yield10 Bioscience4
- Feb 10, 2023Shares withheld for tax 1,029 shares at $3.59 of Yield10 Bioscience5
- Aug 10, 2022Shares withheld for tax 864 shares at $2.68 of Yield10 Bioscience6
- Mar 1, 2022Shares withheld for tax 366 shares at $4.25 of Yield10 Bioscience7
- Feb 10, 2022Granted 5,891 shares at $3.83 of Yield10 Bioscience8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Feb 16, 2024
- 5SEC EDGARForm 4 filed Feb 14, 2023
- 6SEC EDGARForm 4 filed Aug 12, 2022
- 7SEC EDGARForm 4 filed Mar 3, 2022
- 8SEC EDGARForm 4 filed Feb 14, 2022